1NP1 Stock Overview
A venture capital firm specializing in early-stage investments. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Flerie AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 4.17 |
| 52 Week High | SEK 4.24 |
| 52 Week Low | SEK 2.08 |
| Beta | 0 |
| 1 Month Change | 5.98% |
| 3 Month Change | 11.51% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 10.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1NP1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0.6% | -5.2% | 0.5% |
| 1Y | n/a | -10.6% | 15.3% |
Return vs Industry: Insufficient data to determine how 1NP1 performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1NP1 performed against the German Market.
Price Volatility
| 1NP1 volatility | |
|---|---|
| 1NP1 Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1NP1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 1NP1's weekly volatility has decreased from 20% to 5% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 7 | Ted Fjallman | www.flerie.com |
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.
Flerie AB (publ) Fundamentals Summary
| 1NP1 fundamental statistics | |
|---|---|
| Market cap | €332.97m |
| Earnings (TTM) | -€20.16m |
| Revenue (TTM) | €238.70k |
1,395x
P/S Ratio-16.5x
P/E RatioIs 1NP1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1NP1 income statement (TTM) | |
|---|---|
| Revenue | SEK 2.70m |
| Cost of Revenue | SEK 19.70m |
| Gross Profit | -SEK 17.00m |
| Other Expenses | SEK 211.00m |
| Earnings | -SEK 228.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 23, 2025
| Earnings per share (EPS) | -2.92 |
| Gross Margin | -629.63% |
| Net Profit Margin | -8,444.44% |
| Debt/Equity Ratio | 0% |
How did 1NP1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 01:15 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Flerie AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.